Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, featuring promising progress throughout many medical and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, extra dependable option for therapeutic use, specially in drug